| Authors: |
Montiel Equihua C; LifeArc, London, UK., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Areso I; LifeArc, London, UK., Biegel JA; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Blanc P; Imagine for Margo, Saint-Germain-en-Laye, Paris, France., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Daems S; Waterland Private Equity Investments, Antwerp, Belgium.; I3h Institute, Université libre de Bruxelles, Brussels, Belgium., Danielson L; Cancer Research UK, London, UK., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Franke NE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Frühwald MC; Pediatrics and Adolescent Medicine, Swabian Children's Cancer Center, Pediatric Neurooncology, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Gajjar A; Department of Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, USA., Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA., Huang A; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada., Johann PD; Pediatrics and Adolescent Medicine, Swabian Children's Cancer Center, Pediatric Neurooncology, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Kearns P; College of Medicine and Health, University of Birmingham, Birmingham, UK.; Innovative Therapies for Children and Adolescents with Cancer (ITCC), Paris, France., Nysom K; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., O'Connor S; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, Scotland, UK., Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Parker J; LifeArc, London, UK., Patel S; LifeArc, London, UK., Patel S; Cancer Research Horizons, London, UK., Roberts CW; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Williamson D; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Yi JS; Department of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA., Pearson AD; LifeArc, London, UK. andy1pearson@btinternet.com., Jenkinson D; LifeArc, London, UK., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Hopp Children´s Cancer Center (KiTZ), Heidelberg, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Bourdeaut F; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, Paris Cité University, Paris, France. |
